Changes in interleukin‐6 levels during electroconvulsive therapy may reflect the therapeutic response in major depression
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Objective: Interleukin‐6 (IL‐6) has been reported to be elevated in major depressive disorder (MDD) but decreased by antidepressive medication. IL‐6 levels are markedly elevated both after epileptic seizures and single electroconvulsive therapy (ECT) session, but long‐term changes in IL‐6 levels after ECT have not been studied. The correlation between immediate and long‐term changes in proinflammatory cytokines and outcome after ECT was investigated. Method: Thirty patients suffering from MDD participated in the study. IL‐6, interleukin‐1β (IL‐1β) and interleukin‐1 receptor antagonist (IL‐1 RA) levels were examined at baseline and at 2 and 4 h after the first, fifth and the last ECT sessions. The response to ECT was measured with Montgomery‐Åsberg Depression Rating Scale (MADRS). Results: ECT repeatedly caused an increase in IL‐6 levels at the 4‐h time point. However, the baseline IL‐6 levels decreased among remitters, but not among non‐remitters, towards the end of ECT. IL‐1β levels were mostly below detectable level, and IL‐1Ra levels did not change during and after ECT. Conclusion: ECT has distinct acute and long‐term effects on IL‐6 levels. Interestingly, the long‐term effect of ECT on IL‐6 seems to correlate with outcome, providing further evidence of the mechanism of action of ECT and supporting the inflammation theory in MDD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766
Pace, T. W. W., Mletzko, T. C., Alagbe, O., Musselman, D. L., Nemeroff, C. B., Miller, A. H., & Heim, C. M. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1630 · Cited by 810
Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity
Dantzer, R. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.040 · Cited by 743 · cited 2×
“Inflammatory cytokines induce sickness behaviour in animals, which has features strikingly similar to human MDD: anhedonia, anorexia, impaired sleep and reduced locomotor activity associated with alterations in the metabolism of serotonin, norepinephrine and dopamine in the limbic system (amygdala, hippocampus and nuc…”
BackgroundCytokines and psychopathology: Lessons from interferon-α
Capuron, L., & Miller, A. H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.009 · Cited by 562 · cited 1×
“Administrations of IFN-a in may induce depression in humans (30).”
Lindqvist, D., Janelidze, S., Hagell, P., Erhardt, S., Samuelsson, M., Minthon, L., Hansson, O., Björkqvist, M., Träskman-Bendz, L., & Brundin, L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.01.030 · Cited by 524
Self-citationDahl, J., Ormstad, H., Aass, H. C. D., Malt, U. F., Bendz, L. T., Sandvik, L., Brundin, L., & Andreassen, O. A. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.03.019 · Cited by 424 · cited 2×
“In addition, several cytokines that were significantly elevated in patients with depression (including IL-1Ra, IL-6, IL-7, IL-8, IL-10, G-CSF and IFN-c) decreased to levels comparable to those of the healthy controls after 12 weeks of medical therapy among patients who met the recovery criteria (13).”
BackgroundResultEffects of Cytokines on Cerebral Neurotransmission: Comparison with the Effects of Stress
Dunn, A. J., Wang, J., & Ando, T. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_8 · Cited by 316
Capuron, L., Raison, C. L., Musselman, D. L., Lawson, D. H., Nemeroff, C. B., & Miller, A. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.7.1342 · Cited by 308 · cited 1×
“The relevance of these changes in the pathophysiology of depression is supported by the ability of cytokines to induce depression-like symptoms in animals (9, 10) and in humans (11), by modulation of cytokine levels by medical treatment (12, 13) and by electroconvulsive therapy (ECT) (14, 15), and finally, the correla…”
BackgroundHestad, K. A., Tønseth, S., Støen, C. D., Ueland, T., & Aukrust, P. (2003) · The Journal of ECT · doi:10.1097/00124509-200312000-00002 · Cited by 235 · cited 2×
“, where elevated TNF-a levels decreased towards the end of an ECT course (14).”
Background
Cited by
Köhler, C. A., Freitas, T. H., Stubbs, B., Maes, M., Solmi, M., Veronese, N., de Andrade, N. Q., Morris, G., Fernandes, B. S., Brunoni, A. R., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0632-1 · Cited by 449
“Finally, other antidepressant treatment modalities with proven efficacy like electroconvulsive therapy (ECT)may also impact peripheral immune activation notwithstanding evidence remains limited [55, 56].”
Role of Interleukin-6 in Depressive Disorder
Ting, E. Y.-C., Yang, A. C., & Tsai, S.-J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062194 · Cited by 385
Kruse, J. L., Olmstead, R., Hellemann, G., Wade, B., Jiang, J., Vasavada, M. M., Brooks III, J. O., Congdon, E., Espinoza, R., Narr, K. L., et al. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.05.069 · Cited by 46
Kaurani, L., Besse, M., Methfessel, I., Methi, A., Zhou, J., Pradhan, R., Burkhardt, S., Kranaster, L., Sartorius, A., Habel, U., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02582-4 · Cited by 36
Metadata
- Authors
- Järventausta, K., Sorri, A., Kampman, O., Björkqvist, M., Tuohimaa, K., Hämäläinen, M., Moilanen, E., Leinonen, E., Peltola, J., & Lehtimäki, K.
- Venue
- Acta Psychiatrica Scandinavica
- Publisher
- Wiley
- Published
- 2016-11-14
- Volume
- 135
- Issue
- 1
- Pages
- 87-92
- ISSN
- 0001-690X (ISSN-L)
- 1600-0447
- OpenAlex
- W2549722103
- Cited by
- 72
- References
- 12
- FWCI
- 6.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Changes in interleukin‐6 levels during electroconvulsive therapy may reflect the therapeutic response in major depression. https://app.cochat.ai/papers/10.1111/acps.12665
- The paper
- Järventausta, K., Sorri, A., Kampman, O., Björkqvist, M., Tuohimaa, K., Hämäläinen, M., Moilanen, E., Leinonen, E., Peltola, J., & Lehtimäki, K. (2017). Changes in interleukin‐6 levels during electroconvulsive therapy may reflect the therapeutic response in major depression. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/acps.12665
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.